An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic. (24th November 2020) - Gupta, Rishi; Shipa, Muhammad; Yeoh, Su-Ann; Buck, Pauline; Ehrenstein, Michael R